HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
2023 · Cancer Research · 21 citations
https://doi.org/10.1158/0008-5472.can-22-2042
Z
Zhihui Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
64
Citations
4
h-index
2
i10-index
Zhihui Liu is an academic researcher from Lunenfeld-Tanenbaum Research Institute. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Traumatic Brain Injury Research & Nuclear Structure and Function. The author has an h-index of 4, co-authored 34 publications.
ORCID: 0000-0002-5876-0614Papers by this author
worksLineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
2024 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-024-47166-y
Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticity
2024 · The EMBO Journal · 8 citations
https://doi.org/10.1038/s44318-024-00206-1
Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry
2022 · Cell Death and Disease · 5 citations
https://doi.org/10.1038/s41419-022-05314-6
MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma
2025 · Oncogenesis · 4 citations
https://doi.org/10.1038/s41389-025-00557-2
Optimizing the Banking and Releasing Strategies of Clinical‐Grade HLA‐Homozygous Human iPSCs for Regenerative Medicine
2025 · Stem Cells International · 0 citations
https://doi.org/10.1155/sci/3010753
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat